Drager Safety AG & Co. KGaA – Trademark Portfolio
Entity Type: 03
Drager Safety AG & Co. KGaA holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 10 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include UCF, X-PLORE, and PANORAMA NOVA. The owner is based in D-23560 Lubeck.
Revalstr. 1
D-23560 Lubeck , DE
Showing of trademarks Trademarks
Trademark Classifications
Drager Safety AG & Co. KGaA's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Drager Safety AG & Co. KGaA have?
Drager Safety AG & Co. KGaA has 11 U.S. trademarks filed with the USPTO. Of these, 3 registered, 8 cancelled.
What trademark classes does Drager Safety AG & Co. KGaA file in?
Drager Safety AG & Co. KGaA files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Drager Safety AG & Co. KGaA's most well-known trademarks?
Drager Safety AG & Co. KGaA's registered trademark portfolio includes well-known marks such as UCF, X-PLORE, and PANORAMA NOVA. These are among 3 currently registered trademarks in the portfolio.
What is Drager Safety AG & Co. KGaA's trademark registration success rate?
Drager Safety AG & Co. KGaA has a 27% trademark registration rate, with 3 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.